CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

sys6010

mAbexperimentalADC

Clinical trial activity

7 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
5
Phase 3
2
Phase 4
0

Earliest trial started Apr 18, 2024 (NCT07104877)

Timeline

2020s

  1. Jan 1, 2025

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2025

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Payload
unclear

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07251062Phase 2/Phase 3 (Phase 3)Dec 30, 2025Shijiazhuang Pharma Group (CSPC)
NCT07254585Phase 2Dec 1, 2025Shijiazhuang Pharma Group (CSPC)
NCT07256509Phase 2Nov 30, 2025Shijiazhuang Pharma Group (CSPC)
NCT07241936Phase 1/Phase 2 (Phase 2)Nov 13, 2025Shijiazhuang Pharma Group (CSPC)
NCT06927986Phase 3Mar 30, 2025Chinese Academy of Medical Sciences, Shijiazhuang Pharma Group (CSPC)
NCT06775236Phase 1/Phase 2 (Phase 2)Mar 20, 2025Shijiazhuang Pharma Group (CSPC)
NCT07104877N/AApr 18, 2024Fujian Medical University
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Shijiazhuang Pharma Group (CSPC)For profit6622025
Chinese Academy of Medical SciencesAcademic/Hospital1012025
Fujian Medical UniversityAcademic/Hospital1112024
3 organizations
Page 1 / 1